Flow diagram for study selection.

<p>Flow diagram for study selection.</p

Evaluation of feasibility of all methods according to ASSURED criteria.

<p>1† = specificity of these techniques is assumed to be 100%.</p

Summary of published sensitivity and specificity estimates of several molecular methods techniques for HAT.

<p>Summary of published sensitivity and specificity estimates of several molecular methods techniques for HAT.</p

Code for Bayesian mixture model from Evaluating the frequency of asymptomatic Ebola virus infection

Bugs code for Bayesian mixture mode

Results from serological survey from Evaluating the frequency of asymptomatic Ebola virus infection

Table given the measurement from the 4 dilutions of IgG and IgM measurement

Bivariate analysis of MCQ scores associated with health facility properties.

<p>Bivariate analysis of MCQ scores associated with health facility properties.</p

Competence of individual end-users to read and interpret RDT test results expressed as a score on 10.

<p>Competence of individual end-users to read and interpret RDT test results expressed as a score on 10.</p

Characteristics of 680 health facilities, and circumstances of microscopy and malaria RDT use.

<p>TBF Thick blood film; RDT rapid diagnostic test.</p>a<p>besides facilities not specifying the circumstances of use, includes the options: (i) RDT in ward, microscopy in laboratory; (ii) patient follow-up; (iii) person performing the RDT absent; (iv) other.</p>b<p>under the option “other”, 41/47 health facilities indicated themselves to perform RDTs if they were available.</p>c<p>in April 2012.</p

Line intensities for Pf-pLDH, HRP-2 and pan-pLDH in PCR negative and positive study participants.

<p>Pf-pLDH: left, HRP-2: middle, pan-pLDH: right. PCR negative: upper panels, PCR positive: lower panels. RDT number: 1° Paracheck Pf; 2° ICT Malaria Pf Cassette Test; 3° Advantage Pan Malaria Card; 4° Malaria Antigen Pf (HRP-2/pLDH); 5° SD malaria Ag Pf/Pan; 6° SD Malaria Antigen Pf; 7° ICT Malaria Combo Cassette Test; 8° Carestart Malaria HRP2/pLDH (Pf/Pan) Combo Test; 9° Carestart Malaria pLDH (Pf/pan); 10° First Response Malaria Ag (pLDH/HRP2) Combo Rapid Diagnostic Test.</p

Study population and reference test results.

<p>IQR: interquartile range, CI: confidence interval.</p